Evidence map›Paper›PMID 30641125›Full record

ReviewSeminars in cancer biology2019

Metal carcinogen exposure induces cancer stem cell-like property through epigenetic reprograming: A novel mechanism of metal carcinogenesis.

Zhishan Wang, Chengfeng Yang

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in cancer biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Epigenetic downregulation of OEnvironmental pollution (Barking, Essex : 1987) · 2024
    Article
  10. Arsenic-induced prostate cancer: an enigma.Medical oncology (Northwood, London, England) · 2024
    Review
  11. Article
  12. Review
  13. Review
  14. Heavy metals, oxidative stress, and the role of AhR signaling.Toxicology and applied pharmacology · 2024
    Review
  15. Up-regulation of RNA mToxicology and applied pharmacology · 2023
    Article
  16. Review
  17. Epigenetic and epitranscriptomic mechanisms of chromium carcinogenesis.Advances in pharmacology (San Diego, Calif.) · 2023
    Article
  18. Article
  19. The Epitranscriptomic Mechanism of Metal Toxicity and Carcinogenesis.International journal of molecular sciences · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Zhishan WangDepartment of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY, United States. Electronic address: zhishan.wang@uky.edu.
Chengfeng YangDepartment of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY, United States; Center for Research on Environment Disease, College of Medicine, University of Kentucky, Lexington, KY, United States. Electronic address: chengfeng.yang@uky.edu.
University of Kentucky · US

Funding

Pilot Project ProgramP30ES026529 · NIEHS · UNIVERSITY OF KENTUCKY · PI Jason Unrine · 2017 to 2026
$15.4M
MECHANISM OF HEXAVALENT CHROMIUM CARCINOGENESIS ROLE OF LONG NON-CODING RNA DYSREGULATIONR01ES029942 · NIEHS · UNIVERSITY OF KENTUCKY · PI YANG, CHENGFENG · 2019 to 2023
$1.8M
EPIGENETIC MECHANISM OF THE SYNERGISTIC TUMORIGENIC EFFECT OF ARSENICAND BENZO[A]PYRENE CO-EXPOSURER01ES028256 · NIEHS · UNIVERSITY OF KENTUCKY · PI WANG, ZHISHAN · 2018 to 2022
$1.8M
THE EPIGENETIC MECHANISM OF HEXAVALENT CHROMIUM CARCINOGENESISR01ES026151 · NIEHS · UNIVERSITY OF KENTUCKY · PI YANG, CHENGFENG · 2016 to 2020
$1.7M
MGMT DOWN-REGULATION IN THE CARCINOGENICITY OF HEXAVALENT CHROMIUMR01ES029496 · NIEHS · UNIVERSITY OF KENTUCKY · PI WANG, ZHISHAN · 2019 to 2023
$1.7M
NIEHS NIH HHS P30 ES026529NIEHS NIH HHS R01 ES026151NIEHS NIH HHS R01 ES028256NIEHS NIH HHS R01 ES029496NIEHS NIH HHS R01 ES029942
6 · The paper itself

Abstract

Arsenic, cadmium, nickel and hexavalent chromium are among the most common environmental pollutants and potent carcinogens. Chronic exposure to these metals causes various types of cancer in humans, representing a significant environmental health issue. Although under active investigation, the mechanisms of metal carcinogenesis have not been clearly defined. One common feature of these metal carcinogens is that they are all able to cause various epigenetic dysregulations, which are believed to play important roles in their carcinogenicity. However, how metal carcinogen-caused epigenetic dysregulation contributes to metal carcinogenesis remains largely unknown. The evolution of cancer stem cell (CSC) theory has opened exciting new avenues for studying the mechanism of metal carcinogenesis. Increasing evidence indicates that chronic metal carcinogen exposure produces CSC-like cells through dysregulated epigenetic mechanisms. This review will first provide some brief introductions about CSC, epigenetics and epigenetic regulation of CSCs; then summarize progresses in recent studies on metal carcinogen-induced CSC-like property through epigenetic reprograming as a novel mechanism of metal carcinogenesis. Some perspectives for future studies in this field are also presented.

Indexed as

Cellular ReprogrammingAnimalsCarcinogensCell Transformation, NeoplasticEnvironmental ExposureEpigenesis, GeneticHistonesHumansMetalsNeoplasmsNeoplastic Stem CellsProtein Processing, Post-TranslationalCarcinogensHistonesMetalsArsenicCadmiumCancer stem cellCancer stem cell-like cellChromiumDNA methylationEpigeneticsHistone posttranslational modificationMetal carcinogenesismicroRNANickelNon-coding RNA

Identifiers

PMID30641125
PMCPMC6625953
OpenAlexW2909764240

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.